Home » Coronavirus: 160 million cases exceeded. Oxford study: “Risk of side effects with a mix of vaccines”

Coronavirus: 160 million cases exceeded. Oxford study: “Risk of side effects with a mix of vaccines”

by admin

Over 160 million people infected. It is the latest toll recorded worldwide since the pandemic began, according to data from the American university Johns Hopkins. The deaths were over 3.32 million. The United States remains the most affected country in the world in absolute terms by the new coronavirus, with 32.8 million cases and 583,650 deaths. India and Brazil follow.

The number of Covid-19 infections recorded worldwide since the beginning of the pandemic has exceeded 160 million, according to data from the American University Johns Hopkins. The deaths were over 3.32 million. The United States remains the most affected country in the world in absolute terms by the new coronavirus, with 32.8 million cases and 583,650 deaths. India and Brazil follow.

Oxford study: risk of side effects with vaccine mixes

A study conducted by the University of Oxford indicates that adults are more likely to experience mild and moderate side effects after receiving a mix of the AstraZeneca and Pfizer vaccines against Covid-19. Chills, headaches and muscle aches, the most frequently reported side effects following the combination of doses of the different vaccines. Adverse reactions were short-lived, and no other more serious problems were reported. “It’s a really interesting and unexpected discovery,” said Professor Matthew Snape ofOxford Vaccine Group. The study was launched in February. Among the stated goals, to investigate whether administering a different vaccine for the second dose could lead to longer lasting immunity, better protection against new variants, or simply allow clinics to swap vaccines while ruling out adverse effects should an interruption occur. of supplies.

See also  CR39: Cristiano Ronaldo's 39 years told in 39 images

Biden: “Over half of adults have received at least one dose”
US President Joe Biden announced that “over half of adults have received at least one dose” of the Covid-19 vaccine. “Within the next week we should reach 60 percent,” added the head of state speaking to the White House, highlighting “the strong progress” in the immunization campaign. “Tomorrow we will exceed the 250 million vaccine doses administered since we are in office. It’s a truly remarkable achievement for the nation, ”he writes on Twitter.

In the USA 28 cases of thrombosis linked to the Johnson & Johnson vaccine
The administration of the Johnson & Johnson vaccine, which was temporarily suspended by the US FDA on April 13, is linked to 28 cases of thrombosis and three people could have died from this reason. This was stated by experts from the CDC, the highest health authority in the US, explaining that the average age of affected patients is 40 years. In particular, surveys show that patients who have suffered a blood clot are aged between 18 and 59 years. Women between the ages of 30 and 39 would be the most at risk group.

Russia: first cases of Indian variant
In Russia, the first cases of the Indian variant of the coronavirus have been identified. According to Russian media reports, the authorities have recorded 16 cases of this variant among students of Indian nationality at Ulyanovsk State University, about 700 kilometers east of Moscow. The students are now in solitary confinement and monitored by doctors.

See also  Grow a method to walk together

Cuba launches two vaccines, off to population tests
Faced with an increase in coronavirus cases, Cuba this week began immunizing members of the public, using two locally produced vaccines that have yet to complete clinical trials. The island of 11.2 million inhabitants yesterday recorded 1,207 new cases per day – almost a record – as residents of Havana and other provinces received their first dose of Abdala, one of two candidate vaccines in phase 2 of experimentation. The launch began with the blessing of the health ministry, as authorities watch the official approval of the Abdala and Soberana 2 vaccines by the Cuban pharmaceutical authority by June.

The Communist state, which said it wanted to vaccinate all inhabitants this year, has been relatively free from the pandemic, with over 119,000 reported cases and 768 deaths to date. Under US sanctions, Cuba has a long tradition of manufacturing its own vaccines, dating back to the 1980s. Nearly 80% of its vaccines are produced locally, and Cuba is working on five candidate coronavirus vaccines. If one of them gets the green light, it will be the first vaccine developed in Latin America. Cuba has not bought or looked for coronavirus vaccines elsewhere. In March, the country began vaccinating health workers with Abdala and Soberana 2.

In Argentina over 3.2 million cases
Argentina reported 24,475 new cases, bringing the total number of positives to over 3.2 million, while the death toll rose to 68,807, after 496 deaths were reported in the past 24 hours. Argentina recorded a daily record of positive cases on April 16, with 29,472 infections, and a daily high of deaths on May 5, with 663 deaths. For a month, the South American country has been experiencing a dramatic increase in the number of cases, with an increasing level of occupancy of beds in intensive care units.

See also  The incredible discoveries in a dangerous prison in Ecuador that left citizens stunned LaPatilla.com

Faced with this scenario, the government of Alberto Fernandez has extended until May 21 more restrictions in the Buenos Aires area and its suburbs, the most populated area of ​​Argentina, where the majority of cases are recorded. As it faces the onslaught of the second wave of covid-19, Argentina, with a population of around 45 million, continues its vaccination campaign that began in late December. According to official figures, 9,495,304 doses have been administered so far. A total of 7,897,327 people have received the first dose of the vaccine, while 1,597,977 people have already been injected with the second dose.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy